Heroin abuse during pregnancy: Effects on perinatal outcome and early childhood growth

Bertis B Little1, Laura M Snell2, Kraig A Knoll1

  • 1Departments of Obstetrics and Gynecology, The University of Texas Southwestern Medical Center Dallas, Texas 75235-9032.

Insights

Heroin abuse during pregnancy can lead to smaller birth weight in infants. However, studies show that children exposed to heroin in utero generally experience normal postnatal growth and development.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Health
  • Addiction Medicine

Background:

  • Heroin abuse during pregnancy poses risks to both mother and infant.
  • Known risks include fetal growth retardation, neonatal withdrawal syndrome, and maternal complications.
  • Previous small studies suggested normal postnatal development for exposed infants.

Purpose of the Study:

  • To analyze the relationship between heroin use during pregnancy and neonatal outcomes.
  • To assess postnatal growth and development in infants exposed to heroin compared to controls.

Main Methods:

  • A cohort study comparing 47 heroin-abusing mothers and their infants with 80 control women and their infants.
  • Analysis of neonatal outcomes and postnatal growth follow-up data.
  • Medical records were used for growth follow-up of 58% of heroin-exposed and 27.5% of control infants.

Main Results:

  • Infants born to heroin-addicted mothers were significantly smaller at birth (P<.01).
  • No increased frequency of congenital anomalies was observed in heroin-exposed infants compared to controls.
  • Postnatal development in infants exposed to heroin was not delayed.

Conclusions:

  • Heroin exposure in utero is associated with lower birth weight.
  • Congenital anomaly rates are not increased in infants born to mothers with heroin addiction.
  • Postnatal development appears to be within normal variation for heroin-exposed infants.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.4K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.2K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
487